Two Sigma Investments »

Lava Therapeutics Nv shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Lava Therapeutics Nv (LVTX) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Lava Therapeutics Nv

Tip: Access up to 7 years of quarterly data

All positions including Lava Therapeutics Nv held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lava Therapeutics Nv by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2024-06-30 $202k 112k 1.80
2024-03-31 $273k 82k 3.33

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Carnival Corp Unit 99/99/9999 Put Option (CCL)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A (META)
Carvana Cl A (CVNA)
Snowflake Cl A (SNOW)
Bristol Myers Squibb (BMY)
Visa Com Cl A (V)
Costco Wholesale Corporation (COST)
Abbott Laboratories (ABT)
Amazon (AMZN)
Robinhood Mkts Com Cl A (HOOD)
Uber Technologies Put Option (UBER)

View all positions for Two Sigma Investments

Top funds holding Lava Therapeutics Nv

Redmile Group
Bruce & Co
Sphera Funds Management
Two Sigma Investments
Pathway Financial Advisors
Falcon Edge Capital
Susquehanna International
Pnc Financial Services
Tang Capital Management
Two Sigma Advisers
Citadel Advisors
Virtu Financial
Morgan Stanley
Engineers Gate Manager
Geode Capital Management

View all funds holding Lava Therapeutics Nv